Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Measurement of LRRK2 Kinase Activity by Proximity Ligation Assay
Matthew T. Keeney, Eric K. Hoffman, Timothy J. Greenamyre, et al.
BIO-PROTOCOL (2021) Vol. 11, Iss. 17
Open Access | Times Cited: 12

Showing 12 citing articles:

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
Erinc Hallacli, Can Kayatekin, Sumaiya Nazeen, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2035-2056.e33
Open Access | Times Cited: 109
NADPH oxidase 2 activity in Parkinson's disease
Matthew T. Keeney, Eric K. Hoffman, Kyle Farmer, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105754-105754
Open Access | Times Cited: 33
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants
Neda M. Ilieva, Eric K. Hoffman, Mohammed Ghalib, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106522-106522
Open Access | Times Cited: 8
LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson’s disease
Matthew T. Keeney, Emily M. Rocha, Eric K. Hoffman, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 767
Closed Access | Times Cited: 7
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
Belén Fernández, Vinita G. Chittoor-Vinod, Jillian H. Kluss, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 5, pp. 1423-1447
Open Access | Times Cited: 12
An Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s Disease
Tadayuki Komori, Tomoki Kuwahara
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1645-1645
Open Access | Times Cited: 7
NADPH oxidase 2 activity disrupts Calmodulin/CaMKIIα complex via redox modifications of CaMKIIα-contained Cys30 and Cys289: Implications in Parkinson's disease
Filippo Pullara, Madison C. Forsmann, Ignacio J. General, et al.
Redox Biology (2024) Vol. 75, pp. 103254-103254
Open Access | Times Cited: 2
Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
Roberto Di Maio, Matthew T. Keeney, Veronika Cechova, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Nadph Oxidase 2 Activity Disrupts Calmodulin/Camkiia Complex Via Redox Modifications of Camkiia-Contained Cys30 and Cys289: Implications in Parkinson's Disease
Roberto Di Maio, Filippo Pullara, Madison C. Forsman, et al.
(2024)
Closed Access
Redox Modifications of Cys30 and Cys289 Prevent Camkiiα/Calmodulin Interaction: Relevance in Parkinson's Disease
Filippo Pullara, Ignacio J. General, Joseph C. Ayoob, et al.
(2023)
Closed Access
HALLACLI et al. CELL, 2022, all methods v1
Erinc Hallacli
(2022)
Open Access
Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.
Marco Fazzari, Roberto Di Maio, Matthew T. Keeney, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top